Xerostomia (Dry Mouth) Therapeutics Market is anticipated to reach USD 796.1 million by 2025

 The global Xerostomia (Dry Mouth) Therapeutics Market is anticipated to reach USD 796.1 million and is anticipated to grow at a CAGR of 3.2% in the years to come. Xerostomia is a clinical condition of dry mouth and does not show the signs of hyposalivation and symptoms on frequent terms. This condition is observed when the rate of saliva flow is low in comparison with absorption across the oral mucosa coupled with rate of fluid evaporation from the mouth.


Prolonged xerostomia is a significant disease in patients since it affects speech, chewing, denture-wearing, and swallowing activities. The defined causes of hyposalivation and xerostomia are the use of several medications such as antidepressants, anticoagulants, antiretroviral, hypoglycemics, multivitamins and supplements, and anti-inflammatory drugs. Prevalence of xerostomia persists in a large population with different age groups despite following medical or dental consultation.


Rise in use of prescribed medication coupled with rising prevalence of HIV and cancer are expected to act as primary drivers for market growth. Secondary factors such as easy availability of cost-effective medications along with rise in preference for prescription drugs act as market drivers. 


Download Free sample Report https://www.millioninsights.com/industry-reports/xerostomia-dry-mouth-therapeutics-market/request-sample


 In addition, rising cases of depression, Parkinson’s disease, HIV, and hypertension are also expected to contribute significantly to the market development. The market is further triggered by rise in cases of chronic xerostomia due to intake of certain medications. However, significant costs and uneven medical infrastructure arelikely to hinder the market growth in the forecast period upto 2025.


Xerostomia (Dry mouth) therapeutics market is segmented into type, product, and region. Type category includes prescription and OTC. “Over-the-counter (OTC)” segment accounts for a larger share and is expected to gain significant momentum in the forecast period owing to wide variety & availability of branded drugs and low-cost products. Product segmentation includes salivary substitutes, salivary stimulants, and dentrifices. Dentrifices segment accounted for a significant market share owing to effectiveness, affordability and higher adoption.Geographic segmentation for xerostomia (dry mouth) therapeutics industry includes North America, South America, Europe, Asia-Pacific, Middle East and Africa.


Asia-Pacific’s xerostomia therapeutics market is anticipated to rise at a CAGR of 4.2% in the forthcoming period due to rising awareness, high prevalence of Parkinson’s disease, cancer and HIV. North America followed by Europe accounts for a higher revenue share owing to rising prevalence of xerostomia and other dry mouth diseases such as rheumatoid arthritis, Sjogren’s syndrome and HIV along with rising awareness by government and health care NGOs.


The key players in the xerostomia (dry mouth) therapeutics market include GlaxoSmithKline plc; Church & Dwight Co., Inc.; Colgate-Palmolive Company; Hikma Pharmaceuticals PLC; Pendopharm; Sun Pharmaceuticals Industries Ltd.; Lupin Pharmaceuticals, Inc.; Pfizer, Inc.; Parnell Pharmaceuticals, Inc.; Acacia Pharma; and OraCoat.


Market Segment:


Type Outlook (Market Revenue in USD Million, 2014 - 2025)

    • OTC

    • Prescription


Browse Full Research Report with TOC:  

https://www.millioninsights.com/industry-reports/xerostomia-dry-mouth-therapeutics-market


Product Outlook (Market Revenue in USD Million, 2014 - 2025)

    • Salivary Stimulants

    • Salivary Substitutes

    • Dentifrices


Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

        • U.S.

        • Canada

    • Europe

        • Germany

        • UK

    • Asia Pacific

        • China

        • Japan

        • India

    • Latin America

        • Brazil

        • Mexico

    • Middle East & Africa

        • South Africa

continue........


Get In Touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.


Contact Person: 

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com


Global Headquarters

Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Phone: 1-408-610-2300

Email: sales@millioninsights.com


Asia Pacific

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184


Comments

Post a Comment

Popular posts from this blog

(Europe, Middle East and Africa) Herbal Medicine Market Size and Forecast up, 2017: Radiant Insights, Inc

In this report, the EMEA Herbal Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Herbal Medicine for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-herbal-medicine-industry-2017/request-sample EMEA Herbal Medicine market competition by top manufacturers/players, with Herbal Medicine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Tsumura Schwabe Madaus
Read more

Global Digital Pathology Market Researches, Trends and Forecasts to 2025

22-feb-2019 In 2017, the global Digital Pathology market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the global Digital Pathology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Digital Pathology development in United States, Europe and China. The key players covered in this study Danaher Corporation Digipath Glencoe Software Hamamatsu Photonics Indica Labs Koninklijke Philips Nikon Corporation PerkinElmer Pixcelldata Visiopharm Market segment by Type, the product can be split into Whole Slide Imaging Image Analysis Informatics Information Management System Storage & Communication Digital IVD Devices Others (Telepathology) Market segment by Application, split into Educational Clinical Pharma & Biotech Companies Market segment by Regions/Countries, this report covers United Stat
Read more

Global Softgel Capsules Market Demand and Analysis of Key Players – Research Forecast to 2021

13-feb-2019  A Softgel capsule is an oral form of medicine that is usually consists of a gelatin-based shell that has a liquid fill in it. It is basically a mixture of opacifier, gelatin, water, and a plasticizer. The market is currently undergoing a major trend of burgeoning consumer supplements consumption, and growth in the market opportunities.  A wide range of applications are attached with the use of the capsule ranging from formation of anti-inflammatory drugs, antibiotic and antibacterial drugs, cardiovascular therapy drugs, cough and cold preparations, health supplements, and other vitamins and dietary supplements. They are also said to be useful for the preparation of antacid, antiflatulent and antianemic. The product is gaining huge recognition across the globe due to its rising applications and prerequisites. The key factors that are playing a key role in raising the share of the market may include rise in the research and development, rising applications, increasing d
Read more